Post-treatment alpha fetoprotein and platelets predict hepatocellular carcinoma development in dual-infected hepatitis B and C patients after eradication of hepatitis C

We investigated the long-term risk of hepatocellular carcinoma (HCC) in dual-infected hepatitis B and C patients after eradication of hepatitis C virus (HCV). A total of 164 (62% male, median age, 50.5 years) hepatitis B and C dual-infected patients who achieved HCV sustained virological response we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeh, Ming-Lun, Huang, Ching-I, Huang, Chung-Feng, Hsieh, Meng-Hsuan, Hsieh, Ming-Yen, Lin, Zu-Yau, Chen, Shinn-Cherng, Huang, Jee-Fu, Kuo, Po-Lin, Kuo, Hsing-Tao, Dai, Chia-Yen, Yu, Ming-Lung, Chuang, Wan-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844742/
https://www.ncbi.nlm.nih.gov/pubmed/29552306
http://dx.doi.org/10.18632/oncotarget.24219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844742/
https://www.ncbi.nlm.nih.gov/pubmed/29552306
http://dx.doi.org/10.18632/oncotarget.24219

Ejemplares similares